Nuo Therapeutics, Inc. Operating Lease Right-of-Use Assets
Nuo Therapeutics, Inc. (AURX) had Operating Lease Right-of-Use Assets of $61.12 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-14
- 2026-06-30: Operating Lease, Right-of-Use Asset $61.12K.
- 2026-03-31: Operating Lease, Right-of-Use Asset $80.52K.
- 2025-12-31: Operating Lease, Right-of-Use Asset $99.46K.
- 2025-09-30: Operating Lease, Right-of-Use Asset $117.96K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $61.12K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $80.52K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $99.46K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $117.96K 10-Q · filed 2025-10-30 |
| 2025-06-30 | $136.03K 10-Q · filed 2025-07-31 |
| 2025-03-31 | $153.69K 10-Q · filed 2025-04-30 |
| 2024-12-31 | $170.94K 10-K · filed 2026-03-30 |
| 2024-09-30 | $187.81K 10-Q · filed 2024-11-12 |
| 2024-06-30 | $204.30K 10-Q · filed 2024-08-12 |
| 2024-03-31 | $220.43K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $269.35K 10-K · filed 2025-04-01 |
| 2023-09-30 | $292.58K 10-Q · filed 2023-11-20 |
| 2023-06-30 | $315.31K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $337.54K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $359.28K 10-K · filed 2024-04-19 |
| 2022-09-30 | $380.56K 10-Q · filed 2022-11-04 |
| 2022-06-30 | $401.70K 10-Q/A · filed 2022-08-10 |
| 2022-04-01 | $337.23K 10-K · filed 2025-04-01 |
| 2022-03-31 | $84.02K 10-Q · filed 2022-05-16 |
| 2022-01-31 | $89.31K 10-Q · filed 2025-04-30 |
| 2021-12-31 | $0.00 10-K · filed 2023-04-17 |